This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Consiglio Nazionale Delle Ricerche, Consiglio Nazionale Delle Richerche. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2004
Title: Giuliano Elia: Innovator in Anti-Inflammatory Research
Introduction
Giuliano Elia is a notable inventor based in Palestrina, Italy. He has made significant contributions to the field of anti-inflammatory research, holding a total of 3 patents. His work focuses on the development of compounds that inhibit the NF-kB factor, which plays a crucial role in inflammatory responses.
Latest Patents
Elia's latest patents include innovative compounds such as 2-cyclopenten-1-one and its derivatives. These compounds are recognized for their ability to act as inhibitors of the NF-kB factor, showcasing anti-inflammatory, anti-proliferative, immunosuppressive, cytoprotective, and antiviral activities. The substituents in these compounds are carefully selected to ensure they do not affect the NF-kB inhibitory activity, making them valuable in therapeutic applications.
Career Highlights
Throughout his career, Giuliano Elia has worked with esteemed organizations, including the National Research Council of Italy (Consiglio Nazionale Delle Ricerche). His research has contributed to advancements in understanding and treating inflammatory conditions.
Collaborations
Elia has collaborated with notable colleagues such as Antonio Rossi and Maria Gabriella Santoro. These partnerships have further enriched his research and innovation in the field.
Conclusion
Giuliano Elia's work in developing NF-kB inhibitors represents a significant advancement in anti-inflammatory research. His contributions continue to impact the scientific community and pave the way for future innovations in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile